A flawed study should not define a new standard of care

International Journal of Radiation Oncology Biology Physics

Volumn 91, Issue 2, 2015, Pages 255-257

  Hepel, Jaroslaw ^a   Wazer, David E ^a,b  

^a BROWN UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; BREAST CARCINOMA; EDITORIAL; EXTERNAL BEAM RADIOTHERAPY; HEALTH CARE QUALITY; HUMAN; INTRADUCTAL CARCINOMA; INTRAOPERATIVE RADIOTHERAPY; PARTIAL MASTECTOMY; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; RECURRENCE RISK; TARGETED INTRAOPERATIVE RADIATION THERAPY; THERAPY EFFECT; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS;

EID: 84922424046     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.09.019     Document Type: Editorial

References (13)

1. Smyth C. Single-dose radiotherapy eases breast cancer stress. The Times of London; July 25, 2014. http://www.thetimes.co.uk/tto/health/news/article4157186.ece?shareToken=55daafa616d42f8a6e51072c991 c46f5. Accessed September 9, 2014.
2. Vaidya JS, Wenz F, Bulsara M, et al. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomized trial. Lancet 2013;383:603-613.
3. Cuzick J. Radiotherapy for breast cancer, The TARGIT-A trial. Lancet 2014;383:1716.
4. Haviland J, A'Hern R, Bentzen S, et al. Radiotherapy for breast cancer: The TARGIT A trial. Lancet 2014;383:1716-1717.
5. Harness J, Silverstein M, Wazer D, et al. Radiotherapy for breast cancer: The TARGIT A trial. Lancet 2014;383:1718-1719.
6. Yarnold J, Offersen B, Olivotto I, et al. Radiotherapy for breast cancer, The TARGIT A trial. Lancet 2014;383:1717-1718.
7. Mackenzie P, Fyles A, Chung C. Radiotherapy for breast cancer: The TARGIT A trial. Lancet 2014;383:1717.
8. Hughes K, Schnaper L, Bellon J, et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: Long-term follow-up of CALGB 9343. J Clin Oncol 2013;31:2382-2387.
9. Kaufman S, Di Petrillo T, Price LL, et al. Long-term outcome and toxicity in a Phase I/II trial using high-dose-rate multicatheter interstitial brachytherapy for T1/T2 breast cancer. Brachytherapy 2007;6:286-292.
10. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of randomized trials. Lancet 2005;366:2087-2106.
11. Darby SC, Cutter DJ, Boerma M, et al. Radiation-related heart disease: Current knowledge and future prospects. Int J Radiat Oncol Biol Phys 2010;76:656-665.
12. Fisher B, Bryant J, Dignam JJ, et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 2002;20:4141-4149.
13. Fyles AW, McCready DR, Manchul LA, et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 2004;351:963-970.